CClinicalTrials.gg
CompletedNCT07561788Updated May 1, 2026

Cancellous Bone Autograft, Bone Substitute, Local Antibiotic, and Fresh Blood for Ununited Fixed Femoral and Tibial Fractures

An observational study in Cancellous Bone Autograft, Bone Substitute and Local Antibiotic, sponsored by Tanta University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-05-01.

Sponsored by Tanta University · Observational

Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
25
Ages
18 Years to 70 Years
Sex
All
01

Study summary

This study aimed to assess the clinical and radiological outcomes of the usage of autogenous bone graft mixed with bone substitute, fresh blood of patient and local antibiotic used as an onlay graft in treatment of nonunion or delayed union of fixed femoral and tibia fractures.

Read the detailed description

Fractures of long bones as femur and tibia are the third most common ones in orthopedics daily practice, these fractures are usually treated with intramedullary nails.

Union is defined as the appearance bridging callus more than two cortices at the fracture site in the expected time frame for each fracture type which is about 25 weeks for long bones. Nonunion is a problem that has an impact on both patients and society as it may lead to depression, longer time-off work, poor functional outcomes, and cost burdens of secondary interventions to manage.

Different strategies can be used for treatment of such cases. All measures used should follow the diamond concept which summarizes the core factors that need to be present to achieve bone healing. In particular, these factors relate to the optimization of the mechanical stability and biological environment (sufficient osteogenic and angiogenic cells, osteoconductive scaffolds and growth factors).

02

Conditions studied

  • Cancellous Bone Autograft
  • Bone Substitute
  • Local Antibiotic
  • Fresh Blood
  • Ununited Fixed Femoral and Tibial Fractures

Browse trials for

03

In context

Tibial Fractures

159 studies on the registry are indexed under Tibial Fractures; 40 are open to participants now.

This study's enrollment of 25 is below the median of 83 across 46 observational studies indexed under Tibial Fractures.

Browse Tibial Fractures studies →

Lead sponsor

Tanta University is the lead sponsor of 963 studies on the registry; 304 are open to participants now.

Of its 16 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

This retrospective trial was performed on 25 adult individuals underwent revision surgery for non-union of femoral or tibial shaft fractures following definitive fixation by intramedullary nails or Illizarov fixators according to the local potential infection presence.

Inclusion criteria

  • Age from 18 to 70 years old.
  • Both sexes.
  • Patients with complete radiographic and clinical follow-up records for at least 12 months post-revision.

Exclusion criteria

Exclusion Criteria:

- Patients with pathological fractures, infection, or comorbidities that interfere with healing.

05

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
25 participants (actual)
Patient registry
No

Groups and cohorts

  • Study group

    Adult individuals underwent revision surgery for non-union of femoral or tibial shaft fractures following definitive fixation by intramedullary nails or Illizarov fixators

    Procedure: Revision using a composite graft

Interventions

  • ProcedureRevision using a composite graft

    All patients underwent revision using a composite graft and either retained intramedullary nails or Ilizarov fixators.

06

What researchers measure

Primary outcomes

  1. Radiographic union of the fractures

    Radiographic follow-up included evaluating Radiographic Union Score for Tibial Fractures (RUST) were used system to objectively evaluate tibial fractures. RUST assesses union based on four radiographic features: the presence of callus formation, cortical bridging, trabecular bridging, and the degree of alignment at the fracture site. Each feature was scored individually on a scale of 0 to 4, with higher scores indicating better healing.

    Time frame: 6 months post-procedure

Secondary outcomes

  1. Time to union

    Time to union was defined as the duration from surgery to the radiographic evidence of full fracture healing.

    Time frame: Till full fracture healing (Up to 6 months)

  2. Degree of pain

    Pain was assessed via visual analog scale (VAS), a widely used tool where patients rate their pain intensity on a scale from 0 to 10, with 0 being no pain and 10 being the worst possible pain.

    Time frame: 12 months post-procedure

  3. Incidence of postoperative complications

    Incidence of postoperative complications were recorded.

    Time frame: 12 months post-procedure

07

Study locations

1 site
  • Tanta University
    Tanta, El-Gharbia 31527, Egypt
08

References and documents

Individual participant data

Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07561788
Lead sponsor
Tanta University
Responsible party
Ahmed Gamal Ismaiel (Lecturer of Orthopedic Surgery, Tanta University, Tanta, Egypt, Tanta University) — Principal investigator
First posted
May 1, 2026
Start date
Jul 1, 2023
Primary completion
Oct 1, 2024
Completion
Oct 1, 2024
Last update
May 1, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion